Balance is about diversity and diversity is what makes our workplace open and innovative! This #InternationalWomensDay, meet some of the #EUWomen who help create a #BalanceforBetter every day, including our Director-General Anne Bucher! #InspiredbyHer

📢The EU One Health Targeted Stakeholder Consultation on the pilot project ‘Market Launch Intentions of #CentrallyAuthorisedProducts’ is open for feedback until 22 July! ec.europa.eu/health/medicin…

The Government has announced the construction of sections of HS2 will be delayed by two years For more on this and other news visit trib.al/Rx0iR33

We want medicine to be more accessible, available, and affordable. Our #EUPharmaStrategy legislative reform proposes a single market of medicines that: 🔸 is patient-centric 🔹 fosters innovation 🔸 fights antimicrobial resistance 🔹 is environmentally friendly ↓ #HealthUnion

We are building an inclusive and equitable #EUPharmaStrategy driving innovation for patients & industry. Today's proposal ensures more accessible, more affordable and more innovative medicines and will tackle #AMR in a One Health approach. Onwards with the #HealthUnion!

The #EUPharmaStrategy was the result of hard work over three years by a team of excellent dedicated professionals - they deserve a big thank you from all of us #TeamHealthEU Margaritis Schinas Stella Kyriakides EU One Health

Today we propose a major pharmaceuticals reform: → A single market for medicines: affordable, accessible, available for all, everywhere → A framework for easier, speedier innovation and a competitive industry → An initiative to tackle antimicrobial resistance

Preventing shortages of medicines is a crucial objective for a #HealthUnion that protects citizens and health systems. With the pharma reform we propose a new 🇪🇺 alert system to respond to this challenge with EU Medicines Agency and EU HERA at the centre. #EUPharmaStrategy #EPSCO

How new EU incentives will help all patients get the best treatments euronews.com/next/2023/05/1…

Following EU Medicines Agency' positive recommendation, we are authorising the adapted XBB.1.5 COVID-19 vaccine Comirnaty (BioNTech-Pfizer vaccine). This will allow the Member States to prepare in time for their autumn-winter vaccination campaigns. #UnitedInProtection #HealthUnion

After a stringent evaluation by the EU Medicines Agency, we've authorised an adapted COVID-19 vaccine to respond to the new variants. This will allow EU countries to prepare in time for their autumn-winter vaccination campaigns. #HealthUnion

Alzheimer’s is a devastating disease that could affect twice as many people by 2050. Our 2023 #EUPharmaStrategy legislation revision aims to reinforce innovation in Europe to address such unmet medical needs. This is the #HealthUnion euronews.com/next/2023/09/0…

“Blunt threats of moving to China or US should stop,” ⁦Tiemo Wölken 🇪🇺⁩ tells #BigPharma in ⁦ENVI Committee Press⁩ discussion of #EU #pharmaceutical reform

Beating cancer is a necessity. Beating paediatric cancer is an imperative.

Product information for medicines should be easily accessible. Together with the Heads of Medicines Agencies (HMA) & EU Medicines Agency we have published the first electronic product information (ePIs) for selected human medicines harmonised across the EU. #HealthUnion

Through our #PharmaceuticalStrategy we are making the 🇪🇺 a more attractive place for #ClinicalTrials. Very happy to officially launch the #MedEthicsEU special group, which I count on to strengthen cooperation between Member States’ ethics committees. #HealthUnion